Status:
RECRUITING
Whole Body MRI in Oncology
Lead Sponsor:
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Conditions:
Lymphoma
Advanced Prostate Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Multicenter, observational, prospective, study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usua...
Detailed Description
Whole Body-Magnetic Resonance Imaging (WB-MRI) is a radiation-free and, usually, contrast administration-free imaging method for detecting bone and soft tissue pathology. It's part of the "next genera...
Eligibility Criteria
Inclusion
- Patients candidate to WB-MRI according to clinical practice belonging to the study groups listed above.
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged ≥ 18 years.
- Life expectancy greater than 3 months.
Exclusion
- Patients with MRI-unsafe prostheses and devices.
- Patients whose tests are of suboptimal quality, or whose test has been suspended, or is incomplete.
Key Trial Info
Start Date :
October 26 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2031
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06895291
Start Date
October 26 2023
End Date
October 1 2031
Last Update
March 30 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS - Azienda Ospedaliero-Universitaria di Bologna - Policlinico di S. Orsola
Bologna, BO, Italy, 40138
2
IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l.
Meldola, FC, Italy, 47014
3
IRCCS Istituto Europeo di Oncologia S.r.l.
Milan, MI, Italy, 20141